• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT SYPHILIS TP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT SYPHILIS TP Back to Search Results
Catalog Number 08D06-74
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/25/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.This report is being filed on an international product, list number 8d06-74 that has a similar product distributed in the us, list number 8d06-31.
 
Event Description
The customer reported a false nonreactive architect syphilis tp result on one male patient.The following data was provided: on 25mar2020 initial sample = 0.04 s/co (<1.00 s/co = non-reactive), the sample was repeated by domestic luminescence method which = 1.64 s/co and the colloidal gold testing was weakly positive.The riba testing was also negative.There was no impact to patient management reported.
 
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for lot 07413be01, and no trends were identified for the complaint issue.Return testing was not completed as returns were not available.Sensitivity testing was performed with a retained kit of lot 07413be00 (lot number 07413be00 and lot number 07413be01 contain the same bulk material) and a panel.Results of this setup did not implicate that the performance of the lot is negatively impacted.No false non-reactive results were obtained.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect syphilis tp reagent, lot 07413be01.
 
Manufacturer Narrative
Corrected information for section d2 product code from incorrect mtn to correct lip.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT SYPHILIS TP
Type of Device
SYPHILIS
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9967474
MDR Text Key187939785
Report Number3002809144-2020-00328
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 06/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/12/2020
Device Catalogue Number08D06-74
Device Lot Number07413BE01
Was Device Available for Evaluation? No
Date Manufacturer Received06/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LN 03M74-02,; ARCHITECT I2000SR ANALYZER, LN 03M74-02,; ARCHITECT I2000SR ANALYZER, LN 03M74-02,; SERIAL # (B)(4); SERIAL # (B)(4); SERIAL # (B)(4); ARCHITECT I2000SR ANALYZER, LN 03M74-02,; SERIAL # (B)(4).
-
-